Suvretta Capital Management, LLC
Annual return
—
SPY
—
Alpha
—
Invested
$7.8B
Holdings
89
Trades YTD
39
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsIn development
Quarterly performance not yet computed for this fund.
The metrics pipeline computes return / SPY benchmark / alpha per quarter from this fund's 13F holdings and the SPY adj-close. It hasn't produced enough quarters here yet — the chart fills in automatically once at least two are on record.
Top holdings · current snapshot
Source: 13F-HR01
$ARQT
ARCUTIS BIOTHERAPEUTICS INC
Q3 2025: Sold 9.2% (11.54M → 10.48M shares)
7.7%
02
$MANE
VERADERMICS INC
Held since at least Q1 2024
7.0%
03
$SPY
STATE STR SPDR S&P 500 ETF T
Q1 2026: New position (235 shares)
6.0%
04
$PVLA
PALVELLA THERAPEUTICS INC NE
Q3 2025: Increased +15.1% (714.5k → 822.4k shares)
3.8%
05
$APLS
APELLIS PHARMACEUTICALS INC
Q2 2025: Increased +74.8% (1.65M → 2.88M shares)
3.7%
06
$LEGN
LEGEND BIOTECH CORP
Q3 2025: Increased +1.2% (3.77M → 3.82M shares)
3.6%
07
$BNTC
BENITEC BIOPHARMA INC
Q1 2025: Increased +10.2% (8.96M → 9.88M shares)
3.3%
08
$CAPR
CAPRICOR THERAPEUTICS INC
Held since at least Q1 2024
3.1%
09
$RCUS
ARCUS BIOSCIENCES INC
Q2 2025: Increased +44.0% (2.56M → 3.69M shares)
2.9%
10
$EYPT
EYEPOINT INC
Q3 2025: Sold 9.0% (6.80M → 6.19M shares)
2.8%
Recent trades · Last 90 days
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Last refreshed 15:08 UTC.